At TenSixty Biosciences, we are at the forefront of revolutionizing cancer treatment, operating at the cutting-edge intersection of genomics, proteomics, machine learning and cancer biology.
With our focus on harnessing the power of AI and machine learning, we are crafting an innovative atlas of antibody targets on the surface of cancer cells.
.jpeg)
This sets the stage for groundbreaking discoveries of new cancer targets and the development of improved therapeutics.
At TenSixty, we're not just chasing after new targets; we're on a mission to create transformative drugs that will save lives and redefine oncology.
We are an interdisciplinary group of scientists with expertise spanning biology, machine learning, technology development.
.jpg)
.jpg)
